LT2310020T - Nauji 2-deoksi monosacharidų acetatai, turintys priešvėžinį poveikį - Google Patents

Nauji 2-deoksi monosacharidų acetatai, turintys priešvėžinį poveikį

Info

Publication number
LT2310020T
LT2310020T LTEP09794965.5T LT09794965T LT2310020T LT 2310020 T LT2310020 T LT 2310020T LT 09794965 T LT09794965 T LT 09794965T LT 2310020 T LT2310020 T LT 2310020T
Authority
LT
Lithuania
Prior art keywords
acetates
novel
anticancer activity
deoxy
monosaccharides
Prior art date
Application number
LTEP09794965.5T
Other languages
English (en)
Lithuanian (lt)
Inventor
Waldemar Priebe
Marcin Cybulski
Izabela Fokt
Stainslaw Skora
Charles Conrad
Timothy Madden
Original Assignee
Board Of Regents, The University Of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Board Of Regents, The University Of Texas System filed Critical Board Of Regents, The University Of Texas System
Publication of LT2310020T publication Critical patent/LT2310020T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
LTEP09794965.5T 2008-07-11 2009-06-25 Nauji 2-deoksi monosacharidų acetatai, turintys priešvėžinį poveikį LT2310020T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7996808P 2008-07-11 2008-07-11
PCT/US2009/048675 WO2010005799A2 (en) 2008-07-11 2009-06-25 Novel acetates of 2-deoxy monosaccharides with anticancer activity

Publications (1)

Publication Number Publication Date
LT2310020T true LT2310020T (lt) 2017-07-25

Family

ID=41507670

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP09794965.5T LT2310020T (lt) 2008-07-11 2009-06-25 Nauji 2-deoksi monosacharidų acetatai, turintys priešvėžinį poveikį

Country Status (10)

Country Link
US (1) US8927506B2 (enExample)
EP (1) EP2310020B1 (enExample)
JP (2) JP5677951B2 (enExample)
CN (1) CN102149388B (enExample)
DK (1) DK2310020T3 (enExample)
ES (1) ES2628180T3 (enExample)
HU (1) HUE033210T2 (enExample)
LT (1) LT2310020T (enExample)
PL (1) PL2310020T3 (enExample)
WO (1) WO2010005799A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
US8927506B2 (en) 2008-07-11 2015-01-06 Board Of Regents, The University Of Texas System Acetates of 2-deoxy monosaccharides with anticancer activity
WO2012097052A2 (en) * 2011-01-11 2012-07-19 Intertech Bio, Llc Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
WO2012142615A2 (en) * 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders
CN104470543A (zh) * 2012-04-12 2015-03-25 国立大学法人岐阜大学 梗塞治疗用医药组合物
ES2897699T3 (es) 2013-04-05 2022-03-02 Univ Texas Esteres de 2-desoxi-monosacáridos con actividad antiproliferativa
WO2020035782A1 (en) * 2018-08-13 2020-02-20 Dermin Sp. Z O.O. Molecular probes for analysis of metabolism of glycolysis inhibitors prodrugs and synthesis methods therefore
IL296389A (en) 2020-03-16 2022-11-01 Univ Texas Method of treating viral infections with hexose type monosaccharides and analogs thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103197A (en) * 1980-01-21 1981-08-18 Wakamoto Pharmaceut Co Ltd Novel d-glucose derivative and antitumor agent containing the same as active constitutent
JPS58167582A (ja) 1982-03-29 1983-10-03 Takeda Chem Ind Ltd 糖ケタ−ルの製造法
US6319695B1 (en) 1991-10-15 2001-11-20 The Scripps Research Insitute Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
CN1196059A (zh) * 1995-06-23 1998-10-14 牛津糖科学(英国)有限公司 治疗化合物
EE200200565A (et) 2000-03-31 2004-06-15 Angiogene Pharmaceuticals Ltd. Vaskulaarse kahjustava toimega kombinatsioonravi
US6670330B1 (en) 2000-05-01 2003-12-30 Theodore J. Lampidis Cancer chemotherapy with 2-deoxy-D-glucose
CN1541106A (zh) 2001-06-11 2004-10-27 转新疗法公司 用维生素b12和治疗剂联合治疗病毒性、增殖性和炎性疾病的方法
WO2003018598A2 (en) 2001-08-30 2003-03-06 University College Dublin Monosaccharide derivatives
WO2003082301A1 (en) 2002-03-29 2003-10-09 Threshold Pharmaceuticals, Inc. Compositions and methods for treating cancer
AU2004204778B2 (en) * 2003-01-10 2008-05-22 Threshold Pharmaceuticals, Inc. Treatment of cancer with 2-deoxyglucose
CA2431425A1 (en) 2003-06-05 2004-12-05 Angiogene, Inc. Epas1 gene transfer to improve cell therapy
WO2005065721A2 (en) 2003-12-30 2005-07-21 Board Of Regents, The University Of Texas System Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex
WO2006024488A2 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
CN101426508A (zh) 2006-02-24 2009-05-06 得克萨斯系统大学评议会 治疗癌症的己糖化合物
EP1986660A4 (en) 2006-02-24 2009-08-26 Univ Texas HEXOSE COMPOUNDS FOR CANCER TREATMENT
US9149489B2 (en) 2006-04-27 2015-10-06 Board Of Regents, University Of Texas System Inhibitors of glycolysis useful in the treatment of brain tumors
EP1881000A1 (en) * 2006-07-17 2008-01-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
WO2008131024A1 (en) 2007-04-17 2008-10-30 Board Of Regents, The University Of Texas System Iodo-hexose compounds useful to treat cancer
US8927506B2 (en) 2008-07-11 2015-01-06 Board Of Regents, The University Of Texas System Acetates of 2-deoxy monosaccharides with anticancer activity
WO2012142615A2 (en) 2011-04-14 2012-10-18 Board Of Regents, The University Of Texas System Auranofin and auranofin analogs useful to treat proliferative disease and disorders

Also Published As

Publication number Publication date
CN102149388B (zh) 2014-11-05
JP5890043B2 (ja) 2016-03-22
HUE033210T2 (hu) 2017-11-28
EP2310020B1 (en) 2017-03-15
ES2628180T3 (es) 2017-08-02
WO2010005799A3 (en) 2010-04-29
PL2310020T3 (pl) 2017-10-31
US20110160151A1 (en) 2011-06-30
JP5677951B2 (ja) 2015-02-25
EP2310020A2 (en) 2011-04-20
CN102149388A (zh) 2011-08-10
JP2011527678A (ja) 2011-11-04
WO2010005799A2 (en) 2010-01-14
DK2310020T3 (en) 2017-06-26
JP2015091849A (ja) 2015-05-14
US8927506B2 (en) 2015-01-06
EP2310020A4 (en) 2012-04-25

Similar Documents

Publication Publication Date Title
GB2487497B (en) Sensor assembly with filter
IL216639A0 (en) Catheter with single axial sensors
SMT201700309T1 (it) Derivati di chinolin–8–solfonammide aventi un’attività anticancro
GB0902231D0 (en) Catayst
PL2310020T3 (pl) Nowe octany 2-deoksymonosacharydów o aktywności przeciwnowotworowej
EP2245148A4 (en) CELLULASE VARIANTS HAVING GLUCOSE-REDUCED INHIBITION
PL2473518T3 (pl) Stabilizowane ligandy melanokortyny
GB0906157D0 (en) Improved wing structure
PT2504445T (pt) Fermentação de hidratos de carbono
GB0906004D0 (en) MusicStation desktop
EP2407711A4 (en) NUT-SHAPED LED
GB201300934D0 (en) Piezoresistive transducer with low thermal noise
EP2616548A4 (en) NANODEAGGREGATED CELLULOSE
GB0920013D0 (en) Glucose sensor
IL214022A0 (en) Melanocortin analogs with antimicrobial activity
ZA201107395B (en) Enzyme with silaffin
GB201016767D0 (en) Furniture assembly
ZA201107541B (en) An enzyme with a-glucuronidase activity
TWM387880U (en) Architecture structure combined with bamboo
TWM374156U (en) Improved LED structure
HU0900269D0 (en) Synhesis of carbohydrate n-conjugates with bh3-pyridine complex catalyst
TWM372162U (en) Structure improvement of steamer
TWM389196U (en) Lollipop structure with recognizable illumination
TWM389197U (en) Lollipop structure with recognizable illumination
EG26816A (en) Continuous sugar jug